Report Detail
COVID-19 Impact on Global Efavirenz Market Insights, Forecast to 2026
- RnM3983610 |
- 02 June, 2020 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Efavirenz market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Efavirenz market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Efavirenz market is segmented into
Single Efavirenz
Two-drug combination
Three-drug combination
Segment by Application, the Efavirenz market is segmented into
Adults
Children
Regional and Country-level Analysis
The Efavirenz market is analysed and market size information is provided by regions (countries).
The key regions covered in the Efavirenz market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Efavirenz Market Share Analysis
Efavirenz market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Efavirenz business, the date to enter into the Efavirenz market, Efavirenz product introduction, recent developments, etc.
The major vendors covered:
Bristol-Myers Squibb
Teva
Mylan
Aurobindo Pharma
Cipla
Macleods Pharmaceuticals
Hetero
Strides Pharma
Gilead Sciences
1 Study Coverage
- 1.1 Efavirenz Product Introduction
- 1.2 Market Segments
- 1.3 Key Efavirenz Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Efavirenz Market Size Growth Rate by Type
- 1.4.2 Single Efavirenz
- 1.4.3 Two-drug combination
- 1.4.4 Three-drug combination
- 1.5 Market by Application
- 1.5.1 Global Efavirenz Market Size Growth Rate by Application
- 1.5.2 Adults
- 1.5.3 Children
- 1.6 Coronavirus Disease 2019 (Covid-19): Efavirenz Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Efavirenz Industry
- 1.6.1.1 Efavirenz Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Efavirenz Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Efavirenz Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Efavirenz Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Efavirenz Market Size Estimates and Forecasts
- 2.1.1 Global Efavirenz Revenue 2015-2026
- 2.1.2 Global Efavirenz Sales 2015-2026
- 2.2 Efavirenz Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Efavirenz Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Efavirenz Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Efavirenz Competitor Landscape by Players
- 3.1 Efavirenz Sales by Manufacturers
- 3.1.1 Efavirenz Sales by Manufacturers (2015-2020)
- 3.1.2 Efavirenz Sales Market Share by Manufacturers (2015-2020)
- 3.2 Efavirenz Revenue by Manufacturers
- 3.2.1 Efavirenz Revenue by Manufacturers (2015-2020)
- 3.2.2 Efavirenz Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Efavirenz Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Efavirenz Revenue in 2019
- 3.2.5 Global Efavirenz Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Efavirenz Price by Manufacturers
- 3.4 Efavirenz Manufacturing Base Distribution, Product Types
- 3.4.1 Efavirenz Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Efavirenz Product Type
- 3.4.3 Date of International Manufacturers Enter into Efavirenz Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Efavirenz Market Size by Type (2015-2020)
- 4.1.1 Global Efavirenz Sales by Type (2015-2020)
- 4.1.2 Global Efavirenz Revenue by Type (2015-2020)
- 4.1.3 Efavirenz Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Efavirenz Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Efavirenz Sales Forecast by Type (2021-2026)
- 4.2.2 Global Efavirenz Revenue Forecast by Type (2021-2026)
- 4.2.3 Efavirenz Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Efavirenz Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Efavirenz Market Size by Application (2015-2020)
- 5.1.1 Global Efavirenz Sales by Application (2015-2020)
- 5.1.2 Global Efavirenz Revenue by Application (2015-2020)
- 5.1.3 Efavirenz Price by Application (2015-2020)
- 5.2 Efavirenz Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Efavirenz Sales Forecast by Application (2021-2026)
- 5.2.2 Global Efavirenz Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Efavirenz Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Efavirenz by Country
- 6.1.1 North America Efavirenz Sales by Country
- 6.1.2 North America Efavirenz Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Efavirenz Market Facts & Figures by Type
- 6.3 North America Efavirenz Market Facts & Figures by Application
7 Europe
- 7.1 Europe Efavirenz by Country
- 7.1.1 Europe Efavirenz Sales by Country
- 7.1.2 Europe Efavirenz Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Efavirenz Market Facts & Figures by Type
- 7.3 Europe Efavirenz Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Efavirenz by Region
- 8.1.1 Asia Pacific Efavirenz Sales by Region
- 8.1.2 Asia Pacific Efavirenz Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Efavirenz Market Facts & Figures by Type
- 8.3 Asia Pacific Efavirenz Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Efavirenz by Country
- 9.1.1 Latin America Efavirenz Sales by Country
- 9.1.2 Latin America Efavirenz Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Efavirenz Market Facts & Figures by Type
- 9.3 Central & South America Efavirenz Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Efavirenz by Country
- 10.1.1 Middle East and Africa Efavirenz Sales by Country
- 10.1.2 Middle East and Africa Efavirenz Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Efavirenz Market Facts & Figures by Type
- 10.3 Middle East and Africa Efavirenz Market Facts & Figures by Application
11 Company Profiles
- 11.1 Bristol-Myers Squibb
- 11.1.1 Bristol-Myers Squibb Corporation Information
- 11.1.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
- 11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bristol-Myers Squibb Efavirenz Products Offered
- 11.1.5 Bristol-Myers Squibb Recent Development
- 11.2 Teva
- 11.2.1 Teva Corporation Information
- 11.2.2 Teva Description, Business Overview and Total Revenue
- 11.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Teva Efavirenz Products Offered
- 11.2.5 Teva Recent Development
- 11.3 Mylan
- 11.3.1 Mylan Corporation Information
- 11.3.2 Mylan Description, Business Overview and Total Revenue
- 11.3.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Mylan Efavirenz Products Offered
- 11.3.5 Mylan Recent Development
- 11.4 Aurobindo Pharma
- 11.4.1 Aurobindo Pharma Corporation Information
- 11.4.2 Aurobindo Pharma Description, Business Overview and Total Revenue
- 11.4.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Aurobindo Pharma Efavirenz Products Offered
- 11.4.5 Aurobindo Pharma Recent Development
- 11.5 Cipla
- 11.5.1 Cipla Corporation Information
- 11.5.2 Cipla Description, Business Overview and Total Revenue
- 11.5.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Cipla Efavirenz Products Offered
- 11.5.5 Cipla Recent Development
- 11.6 Macleods Pharmaceuticals
- 11.6.1 Macleods Pharmaceuticals Corporation Information
- 11.6.2 Macleods Pharmaceuticals Description, Business Overview and Total Revenue
- 11.6.3 Macleods Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Macleods Pharmaceuticals Efavirenz Products Offered
- 11.6.5 Macleods Pharmaceuticals Recent Development
- 11.7 Hetero
- 11.7.1 Hetero Corporation Information
- 11.7.2 Hetero Description, Business Overview and Total Revenue
- 11.7.3 Hetero Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Hetero Efavirenz Products Offered
- 11.7.5 Hetero Recent Development
- 11.8 Strides Pharma
- 11.8.1 Strides Pharma Corporation Information
- 11.8.2 Strides Pharma Description, Business Overview and Total Revenue
- 11.8.3 Strides Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Strides Pharma Efavirenz Products Offered
- 11.8.5 Strides Pharma Recent Development
- 11.9 Gilead Sciences
- 11.9.1 Gilead Sciences Corporation Information
- 11.9.2 Gilead Sciences Description, Business Overview and Total Revenue
- 11.9.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Gilead Sciences Efavirenz Products Offered
- 11.9.5 Gilead Sciences Recent Development
- 11.1 Bristol-Myers Squibb
- 11.1.1 Bristol-Myers Squibb Corporation Information
- 11.1.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
- 11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bristol-Myers Squibb Efavirenz Products Offered
- 11.1.5 Bristol-Myers Squibb Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Efavirenz Market Estimates and Projections by Region
- 12.1.1 Global Efavirenz Sales Forecast by Regions 2021-2026
- 12.1.2 Global Efavirenz Revenue Forecast by Regions 2021-2026
- 12.2 North America Efavirenz Market Size Forecast (2021-2026)
- 12.2.1 North America: Efavirenz Sales Forecast (2021-2026)
- 12.2.2 North America: Efavirenz Revenue Forecast (2021-2026)
- 12.2.3 North America: Efavirenz Market Size Forecast by Country (2021-2026)
- 12.3 Europe Efavirenz Market Size Forecast (2021-2026)
- 12.3.1 Europe: Efavirenz Sales Forecast (2021-2026)
- 12.3.2 Europe: Efavirenz Revenue Forecast (2021-2026)
- 12.3.3 Europe: Efavirenz Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Efavirenz Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Efavirenz Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Efavirenz Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Efavirenz Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Efavirenz Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Efavirenz Sales Forecast (2021-2026)
- 12.5.2 Latin America: Efavirenz Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Efavirenz Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Efavirenz Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Efavirenz Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Efavirenz Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Efavirenz Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Efavirenz Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Efavirenz Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Efavirenz. Industry analysis & Market Report on COVID-19 Impact on Global Efavirenz is a syndicated market report, published as COVID-19 Impact on Global Efavirenz Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Efavirenz market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
